In today’s GenAI News Briefing, we delve into the rapidly evolving world of generative AI and its burgeoning impact on various sectors, from enterprise software to pharmaceuticals.
Our analysis covers the potential revenue uplift from integrating AI into business processes, IBM’s strategic use of AI bots in consulting, Google’s collaboration with Hugging Face to enhance open-source AI, and Variational AI’s groundbreaking project with Merck in drug discovery.
We also discuss the FTC’s investigation into Big Tech’s AI investments and OpenAI’s latest API updates. Each news item is rated based on its significance, providing you with a clear understanding of its importance and impact.
Timestamps:
0:00 – Introduction
0:30 – Generative AI in Enterprise: Economic Impact
2:00 – IBM’s AI Integration in Consulting
3:30 – Google and Hugging Face’s Open-Source AI Push
5:00 – Variational AI’s Project with Merck: A Pharma Focus
6:30 – FTC Probes Big Tech’s AI Investments
8:00 – OpenAI’s New API Updates: What it Means for Developers
9:30 – Conclusion and Key Takeaways
Join our GAI Insights analyst team every weekday at 7:30 AM ET on LinkedIn or YouTube for comprehensive discussions on AI. Engage with our community live and share your perspectives:
https://www.linkedin.com/company/gai-insights/
Our analysts: Paul Baier, John Sviokla, Tim Andrews, David De Lallo, Tania DiCostanzo, Amanda Fetch, Luda Kopeikina, and Adam Rappaport.
Add comment